These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1696435)

  • 1. Appearance of drug-resistant tumor cells in a maxillary cancer patient undergoing chemotherapy and chemoradiotherapy.
    Kudoh S; Komiyama S; Miyazaki H; Matsui K
    Am J Otolaryngol; 1990; 11(3):165-9. PubMed ID: 1696435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of advanced maxillary carcinoma with cervical lymph node metastases showing a complete response to the combination therapy of CDDP, TS-1 and radiation].
    Hino S; Shintani S; Nonaka T; Hara S; Hamakawa H
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):215-7. PubMed ID: 14997754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis in maxillary sinus cancer cells by 5-fluorouracil, vitamin A and radiation (FAR) therapy.
    Nakashima T; Masuda M; Matsui K; Inokuchi A; Kuraoka A; Komiyama S
    Eur Arch Otorhinolaryngol; 1999; 256 Suppl 1():S64-9. PubMed ID: 10337531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic differentiation and chemosensitivity of human head and neck squamous cell carcinomas.
    Nakashima T; Maehara Y; Kohnoe S; Hayashi I; Katsuta Y
    Head Neck; 1990; 12(5):406-10. PubMed ID: 2211101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental and clinical evaluation by flow cytometry for the mechanism of combination therapy (cisplatin and peplomycin).
    Kawamoto K; Wada Y; Kumazawa H; Yamashita T; Kumazawa T; Matsumura H
    Cytometry; 1992; 13(3):307-13. PubMed ID: 1374308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell line.
    Esaki T; Nakano S; Masumoto N; Fujishima H; Niho Y
    Int J Cancer; 1996 Feb; 65(4):479-84. PubMed ID: 8621231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Flow cytometric DNA analysis and chemosensitivity in squamous cell carcinoma of the head and neck].
    Miyagi M; Soda T; Nakashima T
    Nihon Jibiinkoka Gakkai Kaiho; 1994 Dec; 97(12):2247-58. PubMed ID: 7861297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.
    Ara G; Kusumoto T; Korbut TT; Cullere-Luengo F; Teicher BA
    Cancer Res; 1994 Mar; 54(6):1497-502. PubMed ID: 8137254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
    Okamura M; Hashimoto K; Shimada J; Sakagami H
    Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II).
    Teicher BA; Holden SA; Herman TS; Sotomayor EA; Khandekar V; Rosbe KW; Brann TW; Korbut TT; Frei E
    Int J Cancer; 1991 Jan; 47(2):252-60. PubMed ID: 1846350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of carcinoma of the prostate and testis: experimental study in vivo and in vitro].
    Okada K; Kanamaru H; Yoshiki T; Hashimura T; Nishimura K; Hida S; Nishio Y; Oishi K; Yoshida O; Yamauchi T
    Hinyokika Kiyo; 1988 Nov; 34(11):1911-6. PubMed ID: 2468265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy in the multi-disciplinary treatment of head and neck tumors: evaluation of a chemosensitivity test].
    Saito H
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1744-52. PubMed ID: 3729480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Less cytotoxicity to combination therapy of 5-fluorouracil and cisplatin than 5-fluorouracil alone in human colon cancer cell lines.
    Chen XX; Lai MD; Zhang YL; Huang Q
    World J Gastroenterol; 2002 Oct; 8(5):841-6. PubMed ID: 12378627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemosensitivity of human head and neck tumors detected by human tumor clonogenic assay].
    Suzuki K; Fujii M; Ishii Y; Mochizuki F; Suzuki K; Yamagata M; Suzuki H; Moriya Y; Abiko Y; Sakabe T
    Nichidai Koko Kagaku; 1989 Jun; 15(2):153-6. PubMed ID: 2483253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutation, but not in vitro predictor genes of therapeutic efficacy of cisplatin, is clinically relevant in comparing partial and complete responder cases of maxillary squamous cell carcinoma.
    Kudo I; Esumi M; Kida A; Ikeda M
    Oncol Rep; 2010 Oct; 24(4):851-6. PubMed ID: 20811663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancer of the maxillary antrum--a new multidisciplinary treatment containing neo-adjuvant chemotherapy].
    Inuyama Y; Fujii M; Tnaka J; Takaoka T; Hosoda H; Kohno N
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1165-73. PubMed ID: 6203487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer chemosensitivity profiles of human breast cancer cells assessed by in vitro DNA synthesis inhibition assay.
    Nio Y; Tamura K; Kan N; Inamoto T; Ohgaki K; Kodama H
    Anticancer Res; 2000; 20(2B):1237-44. PubMed ID: 10810427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on chemosensitivity test (in vitro) of cultured human urogenital carcinoma cell lines by MTT assay].
    Lin ST
    Nihon Ika Daigaku Zasshi; 1990 Apr; 57(2):127-36. PubMed ID: 1694861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].
    Sasaki T; Nakamura K; Toba T; Kimura M; Ohga S; Urashima Y; Terashima H; Masuda K
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1417-20. PubMed ID: 12214470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
    Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.